| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.27 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.14 | 0.7 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |